SUTRO BIOPHARMA, INC. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q1 2022 to Q2 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Sutro Biopharma, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q1 2022 to Q2 2023.
  • Sutro Biopharma, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2023 was 0.21 pure.
  • Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
  • Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
  • Sutro Biopharma, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 0.21 Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 0.21 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 0.21 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.